Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
mercaptopurine delayed release (DR6MP)
i
Other names:
DR6MP
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(6)
News
Trials
Company:
Teva
Drug class:
Nerve growth factor inhibitor
Related drugs:
‹
tanezumab (0)
tanezumab (0)
›
Associations
(6)
News
Trials
VERI cancer hierarchy
Reset Filters
NT5C2 K359Q
Leukemia
NT5C2 K359Q
Leukemia
DR6MP
Resistant: D – Preclinical
DR6MP
Resistant
:
D
DR6MP
Resistant: D – Preclinical
DR6MP
Resistant
:
D
NT5C2 R238W
Leukemia
NT5C2 R238W
Leukemia
DR6MP
Resistant: D – Preclinical
DR6MP
Resistant
:
D
DR6MP
Resistant: D – Preclinical
DR6MP
Resistant
:
D
NT5C2 D407A
Leukemia
NT5C2 D407A
Leukemia
DR6MP
Resistant: D – Preclinical
DR6MP
Resistant
:
D
DR6MP
Resistant: D – Preclinical
DR6MP
Resistant
:
D
NT5C2 R367Q
Leukemia
NT5C2 R367Q
Leukemia
DR6MP
Resistant: D – Preclinical
DR6MP
Resistant
:
D
DR6MP
Resistant: D – Preclinical
DR6MP
Resistant
:
D
NF1 mutation
Neurofibrosarcoma
NF1 mutation
Neurofibrosarcoma
DR6MP + JHU395
Sensitive: D – Preclinical
DR6MP + JHU395
Sensitive
:
D
DR6MP + JHU395
Sensitive: D – Preclinical
DR6MP + JHU395
Sensitive
:
D
NF1 mutation
Neurofibrosarcoma
NF1 mutation
Neurofibrosarcoma
DR6MP
Sensitive: D – Preclinical
DR6MP
Sensitive
:
D
DR6MP
Sensitive: D – Preclinical
DR6MP
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.